Marker Therapeutics Investor Relations Material
Latest events
Status Update
Marker Therapeutics
Q1 2025
4 Jun, 2025
Q4 2024
31 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Marker Therapeutics Inc
Access all reports
Marker Therapeutics Inc is a U.S.-based biotechnology company focused on the development of immunotherapies for cancer. The company’s therapeutic approach involves multi-tumor antigen-specific T cell therapies that are designed to target various hematological and solid tumors. It conducts clinical trials and research collaborations to advance its cell therapy platforms. It is headquartered in Houston, Texas, and its shares are listed on the NASDAQ.
Key slides for Marker Therapeutics Inc
Corporate Presentation
Marker Therapeutics Inc
Corporate Presentation
Marker Therapeutics Inc
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
MRKR
Country
🇺🇸 United States